<DOC>
	<DOCNO>NCT02432937</DOCNO>
	<brief_summary>The study primarily aim compare effect two dos Corever placebo patient hypertension .</brief_summary>
	<brief_title>Corever Treatment Hypertension</brief_title>
	<detailed_description>The study aim compare effect two dos Corever placebo patient essential hypertension . Eligible subject belong one follow subtypes plan enrol : ( 1 ) patient essential hypertension without drug control , ( 2 ) uncontrolled hypertension despite treatment 2 antihypertensive agent . Of note , second category receive randomize study treatment addition continue previous medication throughout trial . The study also want investigate safety profile Corever treatment period .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>1 . Patients 2090 year age 2 . Patients belong either one follow category : With essential hypertension , measure office BP antihypertensive treatment screen . With uncontrolled hypertension despite treatment 2 antihypertensive agent , type dose agent shall maintain least 28 day prior enter trial . 3 . Agree able follow study procedure . 4 . Understand nature study , sign informed consent form . 1 . Patients follow condition : Malignant hypertension Secondary hypertension Average sit SBP â‰¥ 180 mmHg Advanced hypertensive retinopathy Type 1 diabetes Acute coronary syndrome Clinical significant valvular disease Hypertrophic cardiomyopathies New York Heart Association class III IV congestive HF Second third degree atrioventricular block history sick sinus syndrome unless pacemaker place Atrial fibrillation Sinus bradycardia ( &lt; 60 bpm ) Asthma Stroke within 3 month Cancer expect survival less 3 year A difference &gt; 20 mmHg SBP &gt; 10 mmHg DBP arm screen Severe hepatic impairment A history serious hypersensitivity reaction . 2 . Patients clinically significant abnormality . 3 . Patients know contraindication Corever . 4 . Female patient pregnant lactate . 5 . 5 . Male female patient childbearing potential agree use effective method contraception study . 6 . Patients currently participate clinical trial within 30 day 7 . Patients need treat permitted medication .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Corever</keyword>
	<keyword>hypertension</keyword>
</DOC>